Research Peptides
99.7% Purity
Research Peptides
5-Amino-1MQ 10 mg — entry-level format for NNMT inhibition and lipid metabolism investigation protocols.
99.7% Purity
Research Peptides
5-Amino-1MQ is a small-molecule inhibitor studied for adipose tissue metabolism and NNMT pathway modulation in metabolic research.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide 20 mg — precision-manufactured triple receptor agonist for metabolic and energy homeostasis research.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.8% Purity
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
99.9% Purity
Research Peptides
Semax is a heptapeptide nootropic studied for cognitive enhancement, neuroprotection, and BDNF modulation in neural research models.
